Ads
related to: monoclonal antibody
Search results
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 5 days agoPreviously, there were no marketed therapies that improved overall survival in patients with...
Transcenta’s Osemitamab succeeds in Phase IIa G/GEJ cancer triple combo trial
Clinical Trials Arena via Yahoo Finance· 6 days agoOsemitamab is a high-affinity humanised anti-CLDN18.2 monoclonal antibody that has shown potent...
FDA approves Amgen’s interchangeable biosimilar Bkemv
Pharmaceutical Technology via Yahoo Finance· 5 days agoBkemv is indicated to treat paroxysmal nocturnal haemoglobinuria (PNH) to lower haemolysis, and for...
New methods available to protect your puppies from the deadly Parvo virus this summer
KULR-8 Billings· 4 days agoTwo of the puppies died from the disease but the other four were saved by a new treatment developed...
Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion...
The Grass Valley Union· 1 day agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology ...
2 Potentially High-Reward Growth Stocks to Buy Right Now
Motley Fool via Yahoo Finance· 5 days agoGrowth stocks have been outpacing value and dividend stocks since 2008, and this performance gap has...
Researchers take step toward development of universal COVID-19 antibodies
telegraphherald.com· 4 days ago"This antibody worked against the original SARS-CoV-2 strain, Omicron and SARS-CoV, providing strong...
Snaking Towards Synthetic Antivenoms
The Scientist· 3 days agoWhile their attacks are defensive, encounters with certain snake species can be fatal. Snakebite envenoming kills more than 100,000 people each year and...
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on...
The Woonsocket Call· 2 days agoAkeso, Inc. (the Company, Akeso, 9926.HK) announced that, on May 24, 2024, Akeso received marketing authorization in China from the National Medical Products Administration (NMPA). The approval ...
Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of...
KOIN News 6 Portland· 10 hours agoKeymed Biosciences Inc. (HKEX: 02162) today announced the long-term efficacy and safety data of a...